UDCA
Accelerated FDA Approval Ushers In New Era in Primary Biliary Cholangitis Treatment
The FDA’s recent accelerated approval of seladelpar for the treatment of PBC is a critical advancement for ...
JANUARY 13, 2025
Pipeline Rich for Bile Acid Drugs
Arlington, Va.—Hepatologists treating patients with cholangiopathies have had few options. But that might be ...
OCTOBER 3, 2018
Load more